Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal Canal

Journal of the National Comprehensive Cancer Network : JNCCN
Van K Morris, Cathy Eng

Abstract

Anal cancer is a rare malignancy for which cisplatin with 5-fluorouracil is the recommended treatment for patients with metastatic disease. Because most cases of anal cancer are linked to prior infection with oncogenic strands of the human papillomavirus, immunotherapeutic approaches have been of great interest in the development of new treatments for this virally driven tumor. This article reviews the early successes of anti-PD-1 therapies and adoptive T-cell therapies for metastatic anal cancer as a potential foundation for novel combination immunotherapy trials in the future.

Citations

May 18, 2019·American Society of Clinical Oncology Educational Book·Cathy EngRob Glynne-Jones
May 13, 2020·Journal for Immunotherapy of Cancer·Alberto PucciniMohamed E Salem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.